Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00532805 · ClinicalTrials.gov registry record
The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency
A clinical trial, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- 49
- Enrollment target
NCT00532805: Completed study, sponsored by Medical University of South Carolina.
NCT00532805 is a clinical trial that has completed, run by Medical University of South Carolina. The registered enrollment target is 49 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00532805 has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- 49 participants
- Enrollment target
Study Summary
Individuals with a deficiency of alpha-1 antitrypsin (AAT) often develop emphysema. Traditional lung function tests may not be the most accurate way to measure the progression of emphysema. This study will compare high resolution computed tomography (CT) scans to spirometry to measure the progression of emphysema.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 49 participants |
| Start Date | 2007-08 |
| Est. Completion | 2012-04 |
What the finished NCT00532805 record still lists
NCT00532805 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 49 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT00532805 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00532805 about?
NCT00532805 is a clinical study titled "The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency". Individuals with a deficiency of alpha-1 antitrypsin (AAT) often develop emphysema. Traditional lung function tests may not be the most accurate way to measure the progression of emphysema. This study will compare high resolution computed tomography (CT) scans to spirometry to measure the progressio...
What is the current status of trial NCT00532805?
This trial is currently completed. The enrollment target is 49 participants. The study started on 2007-08. Estimated completion is 2012-04.
Who is sponsoring clinical trial NCT00532805?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02704858 · 49 participants · Phase 1
Safety and Efficacy Study in Recurrent or Progressive Grade III or IV IDH1 Mutated Glioma
- NCT03516708 · 49 participants · Phase 1
Epacadostat (INCB024360) Added to Preoperative Chemoradiation in Patients With Locally Advanced Rectal Cancer
- NCT03692429 · 49 participants · Phase 1
alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells
- NCT04329494 · 49 participants · Phase 1
PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia